💼 Business 1h ago

Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion

CNBC Business
CNBC business news
View Channel →
Source ↗ 👁 1 💬 0
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.

Comments (0)

Sign in to join the discussion

More Like This

All the reasons Marvell investors are ’freaking out’ as Lumentum deal rumors swirl
MarketWatch.com - Top Stories · 43m ago
Get ready for the ‘Year of Starlink’ as airlines battle over superfast WiFi
MarketWatch.com - Top Stories · 1h ago
This credit card is the ‘best weapon’ to fight debt while interest rates keep climbing
MarketWatch.com - Top Stories · 1h ago
You can’t rely on the S&P 500 as much as you may think
MarketWatch.com - Top Stories · 1h ago
Our church has a $1.5 million bequest earning 3.75% in a bank account. Is inflation eroding it?
MarketWatch.com - Top Stories · 1h ago
Looking for income? These dividend stocks have high yields that seem well supported.
MarketWatch.com - Top Stories · 1h ago